by Stacey Johnson | Jan 31, 2025
In a new location, with highways replacing waterways, it’s comforting to have an agenda with some consistent touchpoints for familiarity, and Advanced Therapies Week 2025 (ATW25), January 20-23 in Dallas, Texas, began with two of my favourites: the Super plenary,...
by Cal Strode | Jan 20, 2025
2025 marks the third time I’ve covered the Alliance for Regenerative Medicine (ARM) State of the Industry Briefing for Signals. In 2024’s installation, I noted the strong emphasis on the cell and gene therapy (CGT) industry’s acceleration, driven by scientific...
by Tyler Wenzel | Jan 16, 2025
Regenerative medicine, the biomedical field that includes the development of cell and gene therapies, is arguably the most exciting research discipline. I often reflect on how lucky I am to have found myself in this area of science. I am always excited to learn and...
by Peace Chukwu | Jan 10, 2025
A challenge in stem cell research and clinical application is the imbalance between demand and the limited availability of these stem cells. This shortage complicates the development of effective therapies and restricts treatment options for patients. Because stem...
by Stacey Johnson | Jan 2, 2025
Happy New Year! With so much information available online, thank you for choosing to read the content on Signals. Whether you are a subscriber and a loyal reader, or you follow a particular blogger or category, your readership is appreciated! As of this writing, here...
Comments